Sign In
Buy ABT
$93.24
+2.73 (+3.02%)
At Close: Jun 25, 2026
Aster Capital Management DIFC Ltd Invests $2.92 Million in Abbott Laboratories $ABT
05:42am, Friday, 27'th Feb 2026
Aster Capital Management DIFC Ltd acquired a new position in shares of Abbott Laboratories (NYSE: ABT) in the third quarter, according to its most recent disclosure with the Securities and Exchange Co
DNB Asset Management AS Reduces Holdings in Abbott Laboratories $ABT
05:00am, Friday, 27'th Feb 2026
DNB Asset Management AS reduced its position in Abbott Laboratories (NYSE: ABT) by 6.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commis
Andra AP fonden Invests $42.72 Million in Abbott Laboratories $ABT
03:13am, Friday, 27'th Feb 2026
Andra AP fonden purchased a new stake in Abbott Laboratories (NYSE: ABT) during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The in
Intuitive Surgical or Abbott: Which MedTech Stock Is a Better Bet Now?
12:25pm, Thursday, 26'th Feb 2026
Both ISRG and ABT closed 2025 on a strong note, but Intuitive Surgical's surging procedure growth and innovation may give it the edge for long-term gains.
Abbott's Meltdown Is Worth Buying, Compelling, Profitable Growth Prospects
06:27am, Thursday, 26'th Feb 2026
Abbott's Meltdown Is Worth Buying, Compelling, Profitable Growth Prospects
Forget Tilray: This Steady Income Stock Beats Wild Cannabis Swings Every Time
09:20am, Wednesday, 25'th Feb 2026
Abbott Labs has raised its dividends for 54 consecutive years. The company expects earnings growth from its acquisition of Exact Sciences.
Abbott (ABT) Ascends While Market Falls: Some Facts to Note
06:50pm, Monday, 23'rd Feb 2026
Abbott (ABT) reached $115.29 at the closing of the latest trading day, reflecting a +2.74% change compared to its last close.
Abbott Labs: A Boring Dividend Machine That Could Quietly Make You Rich
03:00pm, Monday, 23'rd Feb 2026
Abbott Laboratories' business, if not exciting, is resilient and consistent. The company is a leader in multiple markets and has attractive growth avenues.
Abbott (ABT) Reports Q4 Earnings: What Key Metrics Have to Say
10:30am, Monday, 23'rd Feb 2026
While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare
Alliance Wealth Advisors LLC UT Has $2.44 Million Position in Abbott Laboratories $ABT
03:19am, Sunday, 22'nd Feb 2026
Alliance Wealth Advisors LLC UT lowered its stake in Abbott Laboratories (NYSE: ABT) by 30.7% during the third quarter, according to the company in its most recent filing with the Securities and Excha
Exact Sciences Stockholders Approve Acquisition by Abbott
04:05pm, Friday, 20'th Feb 2026
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders vot
Abbott declares 409th consecutive quarterly dividend
11:38am, Friday, 20'th Feb 2026
ABBOTT PARK, Ill., Feb. 20, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share.
BSX vs. ABT: Which MedTech Stock is the Better Investment Now?
10:30am, Friday, 20'th Feb 2026
Abbott edges out Boston Scientific in the MedTech faceoff, with valuation appeal, strong CGM momentum and strategic deals boosting its investment case.
Elefante Mark B Boosts Position in Abbott Laboratories $ABT
06:30am, Friday, 20'th Feb 2026
Elefante Mark B boosted its position in shares of Abbott Laboratories (NYSE: ABT) by 12.7% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. Th
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 18'th Feb 2026
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
